Last update:

Oncology & Cancer news

Oncology & Cancer

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries

Pancreatic cancer remains one of the biggest challenges in the field of oncology. Numbers of cases are increasing, and the latest personalized therapies and immunotherapy are not yet yielding results. Much of the effort is ...

Oncology & Cancer

Targeted radiation therapy shows near-complete response in rare sarcoma patients

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy significantly reduced ...

Oncology & Cancer

Lymph nodes found to be key to successful cancer immunotherapy

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against ...

Oncology & Cancer

Blood test to rule out esophageal cancer

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out esophageal adenocarcinoma ...

Oncology & Cancer

Getting the facts on ovarian cancer

Ovarian cancer is relatively rare. However, it's often fatal in later stages of the disease. The cancer begins in the ovaries and spreads to the abdomen and pelvis if it isn't diagnosed and treated early. It primarily affects ...

Oncology & Cancer

As pesticides and wildfires rise, kids with cancer need resources

A growing body of research ties environmental pollutants to worse health and shorter life spans for childhood cancer survivors. Yet medical providers lack sufficient resources to address these risks with patients, a recent ...

Oncology & Cancer

How small cell lung cancer hijacks neuronal synapses

An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body's neural circuits to grow faster. The finding reveals a startling new dimension of ...

Oncology & Cancer

Repurposing a diabetes medication to prime CAR T cancer targets

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United States. Despite recent advances, the 5-year survival rate for metastatic UC remains about 5% to ...

Oncology & Cancer

Scientists identify novel therapeutic target for ovarian cancer

New research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel therapeutic target that could potentially ...

Oncology & Cancer

GLP-1 receptor agonists may improve lung cancer outcomes

Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes management—fare better than those who don't, according to research led by Sai Yendamuri, MD, MBA, ...